Add BrightSurf on Google Email

New peanut allergy treatment shows effectiveness and safety

A new peanut allergy treatment, sublingual immunotherapy (SLIT), has shown effectiveness in protecting patients from severe allergic reactions. SLIT involves placing tiny amounts of peanut protein under the tongue, where it is absorbed immediately into the bloodstream, desensitizing the immune system to larger amounts of peanut protein.

SourceUniversity of North Carolina Health Care·JournalJournal of Allergy and Clinical Immunology·DateSep 4, 2019

Combination checkpoint blockade effective in pre-surgical setting for early-stage lung cancers

The combination immunotherapy of nivolumab and ipilimumab met the primary endpoint of the NEOSTAR trial with a 33% overall major pathologic response rate in early-stage lung cancer patients. The treatment was also shown to be effective in reducing tumor viability, with six out of 21 patients achieving a complete pathological response.

Cytokine levels could predict immunotherapy problems

Researchers at UT Southwestern Medical Center have identified blood-based biomarkers that may help identify patients at greatest risk of developing autoimmune side effects from immunotherapy. The study found that levels of certain cytokines were particularly low before treatment in patients who developed immune-related adverse events.

SourceUT Southwestern Medical Center·JournalBritish Journal of Cancer·DateOct 31, 2018

Scientists neutralize reactive nitrogen molecules to enhance cancer immunotherapy

Researchers at the University of Notre Dame have found a way to inhibit T-cell activation by targeting nitration of an amino acid in cancer cells. This approach could enhance cancer immunotherapy by identifying activity-based markers and designing approaches that shut down specific mechanisms inhibiting T-cell activation.

SourceUniversity of Notre Dame·JournalProceedings of the National Academy of Sciences·DateOct 29, 2018

Houston Methodist scientists create device to deliver immunotherapy without side effects

Researchers developed a nanofluidic seed that can deliver sustained-release doses of immunotherapy directly to tumors, reducing the need for multiple IV treatments and eliminating side effects. The device has shown promising results in mice models, with equal effectiveness compared to systemic immunotherapy while minimizing toxicities.

SourceHouston Methodist·JournalJournal of Controlled Release·DateOct 23, 2018

Immunotherapy effective against hereditary melanoma

Researchers found that immunotherapy is effective in treating metastatic melanoma in individuals with CDKN2A mutations, with nearly two-thirds of patients responding to treatment. The study suggests that tumours with CDKN2A mutations have a larger number of mutations, making them easier to recognise by the immune system.

SourceKarolinska Institutet·JournalJournal of Medical Genetics·DateOct 8, 2018

In melanoma, radiosurgery may combine well with immunotherapy, especially PD-1 inhibitors

A University of Colorado Cancer Center study shows that combining radiosurgery with immunotherapy, especially PD-1 inhibitors, can significantly improve cancer control and overall survival in melanoma patients. The study found that patients treated with anti-PD-1 therapies had a median brain metastasis-free survival of not reached, whe...

SourceUniversity of Colorado Anschutz Medical Campus·JournalJournal of Neuro-Oncology·DateJun 25, 2018